CATL was founded in 2011. It is one of the first domestic power battery manufacturers with international competitiveness, and focuses on R & D, production and sales of new energy vehicle power battery systems and energy storage systems. CATL is committed to providing first-class solutions for global new energy applications. Its core technologies include the R & D and manufacturing capabilities of the entire industry chain in the fields of power and energy storage batteries, materials, batteries, battery systems, and battery recycling.
CEO： Robin
MontageTechnology is a leading fabless semiconductor provider focusing on the data center and smart home entertainment markets. In the data center market, Montage delivers high-performance, secure and controllable CPU, memory module and memory interface solutions for new generation servers. In the smart home entertainment market, Montage provides highly integrated and customizable OTT/STB total solutions for home entertainment, and offers feature-rich, cost-effective consumer IoT solutions for wireless connectivity everywhere at home. Montage’s sophisticated technology platform allows it to deliver integrated solutions that meet the expanding needs of customers through continuous innovation, efficient design and rapid product development.
CEO： Howard C. Yang
Founded in 1991, Mindray is one of the leading global providers of medical devices and solutions. Headquartered in Shenzhen, China, Mindray possesses a sound global R&D, marketing and service network with subsidiaries and branch offices in 32 countries in North and Latin America, Europe, Africa and Asia-Pacific, as well as 31 branch offices in China. To date, Mindray has nearly 7,600 employees.Today, Mindray’s products and services can be found in healthcare facilities in over 190 countries and regions. In China, Mindray’s products and solutions can be found in nearly 110,000 medical institutions and 99% of Class A tertiary hospitals.
In the process of dismantling the offshore structure of Mindray, V-Capital received the shares held by the foreign shareholders of Mindray by setting fund, and became the shareholder of Mindray before its domestic securitization. At present, the IPO of Mindray has entered the final stage.
CEO： Xu Hang
Founded in 2003, Nanjing Hicin Pharmaceutical Co.,Ltd (300584.SZ) is a High-Tech enterprise specialised in producing pharmaceutical preparations, manufacturing synthetic chemicals, conducting new drug R&D, as well as technical transferring.
It has established several modern workshops GMP-certified for sterile lyophilised powder, cephalosporin lyophilised powder and solid dosage forms (including tablets, capsules and granules) as well as synthetic Active Pharmaceutical Ingredients (APIs). The company produces 7 series of medicine: antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system and immuno-modulate agents, which are processed into several dosage forms.
The company has built a strong R&D team led by PhD and Master’s degree holders, while maintaining extensive collaborations with leading domestic and international research institutions, including the prestigous China Pharmaceutical University. Creating a industry–academia–research innovation model. Through which Hicin has successfully registered and applied for a number of API and formulation products with strong market potential. It has established an innovation cycle of developing, reserving, and producing one generation after another. Thereby ensuring sustainable growth and continuous product innovation.
Holitech Technology Co.,Ltd was founded in 2015 by restructured previous Shandong Liaherd Chemical Industry Co.,Ltd and Jiangxi Holitech Technology Co.,Ltd.Now Jiangxi Holitech Technology Co.,Ltd is a wholly-owned subsidiary of the company.
Founded in 2003, HC-Tech (002185.SZ) is a leading global enterprise specializing in integrated circuit (IC) packaging and testing. Responsible for building semiconductor IC, semiconductor components assembly and testing. HT-tech provides turnkey service for it customers covering package design, package simulation, lead frame packaging, substrate packaging, wafer-level packaging, wafer testing, functional testing, and logistics distribution.
It has advanced technical capabilities, system-level production and quality control that it leverages to ensure high quality products for its users. Establishing itself as the preferred brand in the IC packaging and testing sector by delivering reliable, high-quality solutions that empower its global customer base.
Shanghai Pharma (SPH) is the largest pharmaceutical and the first company in China to be dual-listed by Shanghai (601607.SS) and the Hong Kong (02607.HK) Stock Exchanges. SPH is one of the few listed pharmaceutical companies with a leading position in manufacturing, research, retail and distribution in China. Developing and marketing traditional Chinese medicines and chemical drugs as well. Offering a wide range of pharmaceutical products and supply chain management for them.
